0000939767-18-000100.txt : 20180524
0000939767-18-000100.hdr.sgml : 20180524
20180524201612
ACCESSION NUMBER: 0000939767-18-000100
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180524
FILED AS OF DATE: 20180524
DATE AS OF CHANGE: 20180524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MORRISSEY MICHAEL
CENTRAL INDEX KEY: 0001202096
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30235
FILM NUMBER: 18859429
MAIL ADDRESS:
STREET 1: C/O EXELIXIS INC
STREET 2: 170 HARBOR WAY
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94083
FORMER NAME:
FORMER CONFORMED NAME: MORRISSEY MICHAEL M
DATE OF NAME CHANGE: 20030512
FORMER NAME:
FORMER CONFORMED NAME: MORRISSEY MICHAEL R
DATE OF NAME CHANGE: 20021029
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXELIXIS, INC.
CENTRAL INDEX KEY: 0000939767
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 043257395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0102
BUSINESS ADDRESS:
STREET 1: 210 E. GRAND AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6508377000
MAIL ADDRESS:
STREET 1: 210 E. GRAND AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS INC
DATE OF NAME CHANGE: 20000207
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20000106
4
1
wf-form4_152720735854904.xml
FORM 4
X0306
4
2018-05-24
0
0000939767
EXELIXIS, INC.
EXEL
0001202096
MORRISSEY MICHAEL
C/O EXELIXIS, INC.
210 E. GRAND AVE.
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
President and CEO
Common Stock
2018-05-24
4
M
0
90000
5.50
A
215000
D
Common Stock
2018-05-24
4
S
0
90000
20.55
D
125000
D
Common Stock
176351
I
By Trust
Common Stock
17354
I
By 401(k)
Option (right to buy)
5.5
2018-05-24
4
M
0
90000
0
D
2012-09-28
2018-09-27
Common Stock
90000.0
270000
D
Includes 125,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and excludes 6,653 shares previously owned directly which were contributed to the Morrissey Family Living Trust dated July 21, 1994, as amended.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2018.
Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.22 to $20.72. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.
Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 23, 2018.
The option, representing the right to purchase a total of 450,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 28, 2015.
/s/ Jennifer Drimmer Rokovich, Attorney in Fact
2018-05-24